Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)☆

U WAGNER; A DUBOIS; J PFISTERER; J HUOBER; S LOIBL; H LUCK; J SEHOULI; M GROPP; A STAHLE; B SCHMALFELDT

doi:10.1016/j.ygyno.2006.10.053

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum–taxane based therapy—A phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)☆

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.10.053 ◽

2007 ◽

Vol 105 (1) ◽

pp. 132-137 ◽

Cited By ~ 67

Author(s):

U WAGNER ◽

A DUBOIS ◽

J PFISTERER ◽

J HUOBER ◽

S LOIBL ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

P3-16-06: Phase II Trial of TS-1 in Combination with Oxaliplatin (SOX) in Patients with Metastatic Breast Cancer (MBC) Previously Treated with Anthracycline and Taxane Chemotherapy [TORCH] [Korean Cancer Study Group (KCSG) BR07-03].

10.1158/0008-5472.sabcs11-p3-16-06 ◽

2011 ◽

Author(s):

S-A Im ◽

D-Y Oh ◽

KS Lee ◽

J-H Ahn ◽

J Shon ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Previously Treated ◽

Taxane Chemotherapy

Download Full-text

Phase II Trial of TS-1 in Combination with Oxaliplatin (SOX) in Patients with Metastatic Breast Cancer (MBC) Previously Treated with Anthracycline and Taxane Chemotherapy [TORCH] [Korean Cancer Study Group (KCSG) BR07-03]

Annals of Oncology ◽

10.1016/s0923-7534(20)31962-1 ◽

2012 ◽

Vol 23 ◽

pp. xi18

Author(s):

S.-A. Im ◽

K.H. Lee ◽

D.-Y. Oh ◽

K.S. Lee ◽

J.-H. Ahn ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Previously Treated ◽

Taxane Chemotherapy

Download Full-text

Updated Analysis: Phase II Trial of Combined Chemotherapy with Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients with Metastatic Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group (HGCSG) Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)32186-4 ◽

2012 ◽

Vol 23 ◽

pp. xi82

Author(s):

S. Yuki ◽

Y. Komatsu ◽

H. Nakatsumi ◽

Y. Kobayashi ◽

S. Takeuchi ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Gastrointestinal Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Combined Chemotherapy ◽

Cancer Study ◽

Cancer Study Group ◽

Analysis Phase

Download Full-text

Safety, tolerability and activity of gefitinib (ZD1839) in combination with tamoxifen in ovarian cancer patients refractory to platinum-taxane based therapy – a Phase-II study of the Ovarian Cancer Study Group (AGO Ovar 2.6)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.5016 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 5016-5016

Author(s):

S. Loibl ◽

A. Du Bois ◽

J. Pfisterer ◽

J. Huober ◽

H.-J. Lueck ◽

...

Keyword(s):

Ovarian Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

Phase II Trial of Nilotinib in Patients With Metastatic Malignant Melanoma Harboring KIT Gene Aberration: A Multicenter Trial of Korean Cancer Study Group (UN10‐06)

The Oncologist ◽

10.1634/theoncologist.2015-0161 ◽

2015 ◽

Vol 20 (11) ◽

pp. 1312-1319 ◽

Cited By ~ 30

Author(s):

Su Jin Lee ◽

Tae Min Kim ◽

Yu Jung Kim ◽

Kee‐Taek Jang ◽

Hyo Jin Lee ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Malignant Melanoma ◽

Multicenter Trial ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Kit Gene

Download Full-text

Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2‐positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group

International Journal of Cancer ◽

10.1002/ijc.33696 ◽

2021 ◽

Author(s):

Ralf‐Dieter Hofheinz ◽

Susanne Hegewisch‐Becker ◽

Volker Kunzmann ◽

Peter Thuss‐Patience ◽

Martin Fuchs ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Study Group ◽

Her2 Positive ◽

Cancer Study ◽

Cancer Study Group ◽

Gastric Cancer Study ◽

Esophagogastric Adenocarcinoma

Download Full-text

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Case Medical Research ◽

10.31525/ct1-nct04230759 ◽

2020 ◽

Author(s):

Keyword(s):

Phase Ii ◽

Anal Cancer ◽

Phase Ii Trial ◽

Locally Advanced ◽

Anal Carcinoma ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Randomized Phase Ii

Download Full-text

HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4073 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4073-4073 ◽

Cited By ~ 19

Author(s):

Ralf Hofheinz ◽

Susanna Hegewisch-Becker ◽

Peter C. Thuss-Patience ◽

Volker Kunzmann ◽

Martin Fuchs ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Study Group ◽

Her2 Positive ◽

Cancer Study ◽

Cancer Study Group ◽

Gastric Cancer Study ◽

Esophagogastric Adenocarcinoma

Download Full-text

Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1069-7 ◽

2009 ◽

Vol 65 (4) ◽

pp. 641-647 ◽

Cited By ~ 40

Author(s):

Joung-Soon Jang ◽

Ho Yeong Lim ◽

In Gyu Hwang ◽

Hong Suk Song ◽

NaeChoon Yoo ◽

...

Keyword(s):

Bladder Cancer ◽

Gall Bladder ◽

Phase Ii ◽

Phase Ii Trial ◽

Gall Bladder Cancer ◽

Study Group ◽

Biliary Cancer ◽

Cancer Study ◽

Cancer Study Group

Download Full-text

Phase II Trial of Combined Chemotherapy with Irinotecan, S-1, and Bevacizumab (IRIS/BEV) In Patients with Metastatic Colorectal Cancer -Updated Analysis-. Hokkaido Gastrointestinal Cancer Study Group (HGCSG) Trial

Annals of Oncology ◽

10.1016/s0923-7534(20)33205-1 ◽

2012 ◽

Vol 23 ◽

pp. ix202

Author(s):

K. Hatanaka ◽

S. Yuki ◽

T. Miyagishima ◽

T. Kato ◽

M. Nakamura ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Phase Ii ◽

Gastrointestinal Cancer ◽

Phase Ii Trial ◽

Study Group ◽

Combined Chemotherapy ◽

Cancer Study ◽

Cancer Study Group

Download Full-text